Healthcare Sector
Biotechnology & Drugs Industry 
|
|
|
Data by Company within Biotechnology & Drugs Industry
|
|
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
Company |
(Millions) |
(Millions) |
(Millions) |
Number |
Abbvie inc |
$ 192,531 |
$ 45,804 |
$ 4,622 |
26,000 |
Amgen Inc |
$ 131,578 |
$ 32,341 |
$ 7,264 |
17,900 |
Gilead Sciences Inc |
$ 77,732 |
$ 24,689 |
$ 89 |
7,000 |
Allergan plc |
$ 64,063 |
$ 16,096 |
$ -2,479 |
10,500 |
Biogen Inc |
$ 42,024 |
$ 13,445 |
$ 4,061 |
7,550 |
Royalty Pharma Plc |
$ 34,473 |
$ 2,122 |
$ 1,702 |
- |
Seagen Inc |
$ 30,451 |
$ 2,176 |
$ 614 |
- |
Immunomedics Inc |
$ 19,795 |
$ 2 |
$ -354 |
- |
Avantor Inc |
$ 16,527 |
$ 6,394 |
$ 117 |
- |
Bio techne Corp |
$ 14,561 |
$ 799 |
$ 175 |
- |
Novavax Inc |
$ 14,233 |
$ 205 |
$ -273 |
- |
Quidel Corp |
$ 14,104 |
$ 1,662 |
$ 810 |
- |
Livongo Health Inc |
$ 13,683 |
$ 120 |
$ 7 |
- |
Myokardia Inc |
$ 11,943 |
$ 22 |
$ -277 |
- |
Repligen Corp |
$ 11,827 |
$ 366 |
$ 60 |
- |
Qiagen N v |
$ 11,339 |
$ 1,526 |
$ -41 |
- |
Neurocrine Biosciences Inc |
$ 10,644 |
$ 788 |
$ 37 |
- |
Kite Pharma, Inc. |
$ 10,187 |
$ 32 |
$ -359 |
- |
Juno Therapeutics, Inc. |
$ 9,815 |
$ 112 |
$ -437 |
- |
Denali Therapeutics Inc |
$ 9,706 |
$ 336 |
$ 143 |
- |
Crispr Therapeutics Ag |
$ 8,973 |
$ 1 |
$ -349 |
- |
Acceleron Pharma inc |
$ 8,216 |
$ 93 |
$ -166 |
- |
Vir Biotechnology Inc |
$ 7,983 |
$ 76 |
$ -299 |
- |
Fate Therapeutics inc |
$ 7,847 |
$ 31 |
$ -173 |
- |
Halozyme Therapeutics Inc |
$ 6,817 |
$ 268 |
$ 129 |
- |
Pactiv Evergreen Inc |
$ 6,450 |
$ 9,716 |
$ 106 |
- |
Momenta Pharmaceuticals inc |
$ 6,187 |
$ 30 |
$ -228 |
- |
Reynolds Consumer Products Inc |
$ 5,793 |
$ 3,263 |
$ 363 |
- |
Emergent Biosolutions Inc |
$ 5,318 |
$ 1,555 |
$ 305 |
- |
Tg Therapeutics inc |
$ 5,216 |
$ 0 |
$ -303 |
- |
Adaptimmune Therapeutics Plc |
$ 5,145 |
$ 6 |
$ -130 |
- |
Actavis Plc |
$ 4,714 |
$ 10,573 |
$ -751 |
19,200 |
Eidos Therapeutics Inc |
$ 4,691 |
- |
$ -101 |
- |
Beam Therapeutics Inc |
$ 4,406 |
$ 1,335 |
$ 23 |
- |
Neogen Corp |
$ 4,375 |
$ 433 |
$ 60 |
- |
Spark Therapeutics Inc |
$ 4,257 |
$ 58 |
$ -80 |
- |
Springworks Therapeutics Inc |
$ 4,072 |
- |
$ -46 |
- |
Intellia Therapeutics inc |
$ 3,708 |
$ 58 |
$ -134 |
- |
Nantkwest Inc |
$ 3,519 |
$ 0 |
$ -76 |
- |
Amyris Inc |
$ 3,350 |
$ 134 |
$ -294 |
440 |
Revolution Medicines Inc |
$ 2,684 |
- |
$ 0 |
- |
Igm Biosciences Inc |
$ 2,679 |
- |
$ -47 |
- |
Audentes Therapeutics Inc |
$ 2,664 |
- |
$ -166 |
- |
Nanostring Technologies Inc |
$ 2,658 |
$ 118 |
$ -63 |
- |
Cytodyn Inc |
$ 2,612 |
- |
$ -159 |
- |
Vericel Corporation |
$ 2,499 |
$ 124 |
$ 3 |
- |
Fulgent Genetics Inc |
$ 2,384 |
$ 135 |
$ 48 |
- |
Myriad Genetics Inc |
$ 2,278 |
$ 598 |
$ -194 |
- |
Arcus Biosciences Inc |
$ 2,246 |
$ 78 |
$ -123 |
- |
Quanterix Corp |
$ 2,145 |
$ 29 |
$ -24 |
- |
Bluebird Bio Inc |
$ 2,068 |
$ 251 |
$ -619 |
- |
Heska Corporation |
$ 1,963 |
$ 200 |
$ -17 |
- |
Riot Blockchain Inc |
$ 1,958 |
$ 8 |
$ -20 |
- |
Biocryst Pharmaceuticals Inc |
$ 1,903 |
$ 54 |
$ -125 |
- |
Madrigal Pharmaceuticals Inc |
$ 1,875 |
- |
$ -202 |
- |
Zymeworks Inc |
$ 1,857 |
$ 39 |
$ -181 |
- |
Cannis Inc |
$ 1,712 |
$ 4 |
$ -2 |
- |
Replimune Group Inc |
$ 1,710 |
- |
$ -32 |
- |
Sangamo Therapeutics Inc |
$ 1,628 |
$ 118 |
$ -121 |
- |
Frequency Therapeutics Inc |
$ 1,628 |
$ 3 |
$ -16 |
- |
Establishment Labs Holdings Inc |
$ 1,621 |
$ 35 |
$ -28 |
- |
Scholar Rock Holding Corp |
$ 1,606 |
$ 9 |
$ -36 |
- |
Regenxbio Inc |
$ 1,590 |
$ 154 |
$ -107 |
- |
Alder Biopharmaceuticals Inc |
$ 1,579 |
- |
$ -317 |
- |
Krystal Biotech Inc |
$ 1,552 |
- |
$ -27 |
- |
Ocugen Inc |
$ 1,550 |
- |
$ -22 |
- |
Immunovant Inc |
$ 1,545 |
- |
$ -135 |
- |
Phathom Pharmaceuticals Inc |
$ 1,470 |
- |
$ -7 |
- |
Allovir Inc |
$ 1,375 |
- |
$ 0 |
- |
Atara Biotherapeutics Inc |
$ 1,362 |
- |
$ -317 |
- |
Coherus Biosciences inc |
$ 1,355 |
$ 476 |
$ 132 |
- |
Capstone Therapeutics Corp. |
$ 1,305 |
- |
$ -4 |
- |
Biondvax Pharmaceuticals Ltd |
$ 1,300 |
- |
$ -109 |
- |
Bionano Genomics Inc |
$ 1,294 |
$ 7 |
$ -37 |
- |
Adverum Biotechnologies Inc |
$ 1,140 |
$ 2 |
$ -99 |
- |
Syndax Pharmaceuticals Inc |
$ 1,078 |
$ 2 |
$ -71 |
- |
Celldex Therapeutics Inc |
$ 1,064 |
$ 5 |
$ -48 |
- |
Black Diamond Therapeutics Inc |
$ 1,006 |
- |
$ 0 |
- |
Aclaris Therapeutics Inc |
$ 971 |
$ 6 |
$ -51 |
- |
Acorda Therapeutics inc |
$ 967 |
$ 165 |
$ 49 |
- |
Albany Molecular Research Inc |
$ 928 |
$ 681 |
$ -60 |
- |
Meridian Bioscience Inc |
$ 923 |
$ 299 |
$ 70 |
- |
Cellectis S a |
$ 911 |
$ 15 |
$ -115 |
- |
Protagonist Therapeutics inc |
$ 881 |
$ 25 |
$ -65 |
- |
Chromadex Corporation |
$ 859 |
$ 57 |
$ -23 |
- |
Aerie Pharmaceuticals Inc |
$ 845 |
$ 83 |
$ -183 |
- |
G1 Therapeutics Inc |
$ 841 |
- |
$ -99 |
- |
Rubius Therapeutics inc |
$ 840 |
- |
$ -168 |
- |
Nightstar Therapeutics Plc |
$ 840 |
- |
$ -53 |
- |
Anavex Life Sciences Corp |
$ 837 |
$ 1 |
$ -28 |
- |
Clementia Pharmaceuticals Inc. |
$ 836 |
- |
$ 0 |
- |
Vaxart Inc |
$ 787 |
$ 4 |
$ -32 |
- |
Bionovate Technologies Corp |
$ 751 |
- |
$ 0 |
- |
Compugen Ltd |
$ 743 |
$ 2 |
$ -30 |
- |
Pulse biosciences inc |
$ 738 |
$ 0 |
$ -50 |
- |
Agenus Inc |
$ 731 |
$ 91 |
$ -176 |
- |
Aslan Pharmaceuticals Ltd |
$ 718 |
$ 3 |
$ -47 |
- |
Cellect Biotechnology Ltd |
$ 710 |
- |
$ 5 |
- |
Gossamer Bio Inc |
$ 689 |
- |
$ -243 |
- |
Cel sci Corporation |
$ 688 |
- |
$ -33 |
- |
Osiris Therapeutics, Inc. |
$ 656 |
$ 113 |
$ 5 |
- |
Merus N v |
$ 654 |
- |
$ 0 |
- |
Neoleukin Therapeutics Inc |
$ 652 |
- |
$ -29 |
- |
Oxford Immunotec Global Plc |
$ 568 |
$ 57 |
$ -17 |
- |
Evelo Biosciences Inc |
$ 562 |
- |
$ -87 |
- |
Curis Inc |
$ 537 |
$ 11 |
$ -31 |
- |
Relmada Therapeutics Inc |
$ 535 |
- |
$ -43 |
- |
Urovant Sciences Ltd |
$ 519 |
- |
$ -164 |
- |
Oyster Point Pharma Inc |
$ 513 |
- |
$ -32 |
- |
Gritstone Oncology Inc |
$ 512 |
$ 4 |
$ -106 |
- |
Homology Medicines Inc |
$ 486 |
$ 2 |
$ -124 |
- |
Quotient Limited |
$ 454 |
$ 42 |
$ -95 |
- |
Rapt Therapeutics Inc |
$ 444 |
- |
$ -30 |
- |
Jounce Therapeutics inc |
$ 444 |
$ 148 |
$ -282 |
- |
Urogen Pharma Ltd |
$ 420 |
$ 8 |
$ -137 |
- |
89bio Inc |
$ 415 |
- |
$ 18 |
- |
Portage Biotech Inc |
$ 408 |
- |
$ -7 |
- |
Cue Biopharma Inc |
$ 404 |
$ 6 |
$ -43 |
- |
Spero Therapeutics Inc |
$ 399 |
$ 11 |
$ -85 |
- |
Solid Biosciences Inc |
$ 385 |
- |
$ -99 |
- |
Cellular Biomedicine Group Inc |
$ 384 |
$ 0 |
$ -55 |
- |
Lixte Biotechnology Holdings Inc |
$ 374 |
- |
$ -3 |
- |
Cardiff Oncology Inc |
$ 370 |
$ 0 |
$ -23 |
- |
Cytomx Therapeutics Inc |
$ 366 |
$ 100 |
$ -33 |
- |
Assembly Biosciences Inc |
$ 361 |
$ 79 |
$ -62 |
- |
Wave Life Sciences Ltd |
$ 361 |
$ 13 |
$ -178 |
- |
Unity Biotechnology Inc |
$ 357 |
- |
$ -92 |
- |
Lineage Cell Therapeutics Inc |
$ 345 |
$ 3 |
$ -27 |
- |
Aptose Biosciences Inc |
$ 340 |
- |
$ -48 |
- |
Surface Oncology Inc |
$ 339 |
$ 40 |
$ -24 |
- |
Oncocyte Corp |
$ 331 |
- |
$ -32 |
- |
Biofrontera Ag |
$ 313 |
$ 24 |
$ -10 |
- |
Eiger Biopharmaceuticals Inc |
$ 304 |
- |
$ -63 |
- |
Neuronetics Inc |
$ 293 |
$ 51 |
$ -31 |
- |
Casi Pharmaceuticals Inc |
$ 290 |
$ 12 |
$ -55 |
- |
Enochian Biosciences Inc |
$ 282 |
- |
$ -11 |
- |
Pdl Biopharma Inc |
$ 279 |
$ 13 |
$ -155 |
- |
Vaxcyte Inc |
$ 278 |
- |
$ 0 |
- |
Cerecor Inc |
$ 267 |
- |
$ -30 |
- |
Outlook Therapeutics Inc |
$ 264 |
- |
$ -45 |
- |
Galera Therapeutics Inc |
$ 261 |
- |
$ -41 |
- |
Cabaletta Bio Inc |
$ 253 |
- |
$ -19 |
- |
Forma Therapeutics Holdings Inc |
$ 229 |
- |
$ 0 |
- |
Therapeutic Solutions International Inc |
$ 219 |
$ 0 |
$ -2 |
- |
Voyager Therapeutics Inc |
$ 214 |
$ 171 |
$ 37 |
- |
Axcella Health Inc |
$ 211 |
- |
$ -57 |
- |
Genocea Biosciences Inc |
$ 207 |
$ 10 |
$ -44 |
- |
Core Lithium Corp. |
$ 203 |
- |
$ -4 |
- |
Adma Biologics Inc |
$ 203 |
$ 40 |
$ -67 |
- |
Scpharmaceuticals Inc |
$ 202 |
- |
$ -35 |
- |
Vistagen Therapeutics Inc |
$ 200 |
- |
$ -16 |
- |
Berkeley Lights Inc |
$ 193 |
- |
$ 0 |
- |
Foamix Pharmaceuticals Ltd |
$ 193 |
$ 3 |
$ 95 |
68 |
Volitionrx Ltd |
$ 192 |
$ 0 |
$ -19 |
- |
Infinity Pharmaceuticals Inc |
$ 184 |
$ 2 |
$ -41 |
23 |
Relay Therapeutics Inc |
$ 182 |
- |
$ 0 |
- |
Eloxx Pharmaceuticals Inc |
$ 181 |
- |
$ -46 |
- |
Strongbridge Biopharma plc |
$ 180 |
$ 28 |
$ -42 |
- |
Nymox Pharmaceutical Corporation |
$ 180 |
$ 0 |
$ -13 |
- |
Surgalign Holdings Inc |
$ 179 |
$ 255 |
$ -134 |
- |
Champions Oncology Inc |
$ 176 |
$ 37 |
$ -2 |
- |
Pluristem Therapeutics Inc |
$ 163 |
$ 1 |
$ -37 |
- |
Protalix Biotherapeutics inc |
$ 161 |
$ 47 |
$ -7 |
- |
Ayala Pharmaceuticals Inc |
$ 155 |
- |
$ 0 |
- |
Erytech Pharma S a |
$ 154 |
- |
$ -70 |
- |
Idera Pharmaceuticals Inc |
$ 153 |
$ 1 |
$ -59 |
- |
Dimension Therapeutics, Inc. |
$ 149 |
$ 17 |
$ -56 |
- |
Orgenesis Inc |
$ 148 |
$ 14 |
$ -45 |
- |
Poseida Therapeutics Inc |
$ 148 |
- |
$ 0 |
- |
Dyadic International Inc |
$ 146 |
$ 2 |
$ -6 |
- |
La Jolla Pharmaceutical Company |
$ 143 |
$ 30 |
$ -61 |
- |
Catalyst Biosciences Inc |
$ 133 |
$ 1 |
$ -51 |
- |
Eyenovia Inc |
$ 132 |
- |
$ -21 |
- |
Applied Genetic Technologies Corp |
$ 131 |
$ 42 |
$ -57 |
- |
Oncternal Therapeutics Inc |
$ 131 |
$ 3 |
$ -15 |
- |
Tracon Pharmaceuticals Inc |
$ 130 |
$ 11 |
$ -17 |
- |
Brainstorm Cell Therapeutics Inc |
$ 124 |
- |
$ -32 |
- |
Capricor Therapeutics Inc |
$ 122 |
$ 0 |
$ -11 |
- |
Apollo Endosurgery inc |
$ 120 |
$ 42 |
$ -23 |
- |
Cytrx Corp |
$ 114 |
- |
$ -8 |
- |
Citius Pharmaceuticals Inc |
$ 113 |
- |
$ -21 |
1 |
Protara Therapeutics Inc |
$ 109 |
- |
$ -27 |
- |
Aptevo Therapeutics Inc |
$ 106 |
$ 32 |
$ -19 |
- |
Aytu Bioscience Inc |
$ 102 |
$ 52 |
$ -22 |
- |
Cidara Therapeutics Inc |
$ 100 |
$ 12 |
$ -72 |
- |
Satsuma Pharmaceuticals Inc |
$ 99 |
- |
$ -27 |
- |
Regenerx Biopharmaceuticals Inc |
$ 99 |
$ 0 |
$ -2 |
- |
Cocrystal Pharma Inc |
$ 90 |
$ 2 |
$ -56 |
- |
Organovo Holdings Inc |
$ 87 |
$ 3 |
$ -17 |
- |
Axim Biotechnologies Inc |
$ 86 |
$ 1 |
$ -4 |
- |
Twinlab Consolidated Holdings Inc |
$ 85 |
$ 63 |
$ -36 |
- |
Windtree Therapeutics Inc |
$ 85 |
$ 1 |
$ -32 |
- |
Kitov Pharma Ltd |
$ 81 |
$ 1 |
$ 6 |
- |
Acasti Pharma Inc |
$ 80 |
- |
$ 0 |
- |
Aerpio Pharmaceuticals Inc |
$ 75 |
- |
$ -4 |
- |
Organicell Regenerative Medicine Inc |
$ 74 |
$ 3 |
$ -13 |
- |
Diffusion Pharmaceuticals Inc |
$ 73 |
- |
$ -16 |
- |
Aim Immunotech Inc |
$ 70 |
$ 0 |
$ -12 |
- |
Uluru Inc. |
$ 69 |
$ 1 |
$ -2 |
- |
Petvivo Holdings Inc |
$ 68 |
$ 0 |
$ -4 |
4 |
Cv Sciences Inc |
$ 65 |
$ 29 |
$ -20 |
- |
Pharmacyte Biotech Inc |
$ 65 |
- |
$ -3 |
- |
Navidea Biopharmaceuticals Inc |
$ 62 |
$ 1 |
$ -11 |
- |
Allena Pharmaceuticals Inc |
$ 61 |
- |
$ -34 |
- |
Creative Medical Technology Holdings Inc |
$ 60 |
- |
$ 0 |
- |
Optec International, Inc. |
$ 59 |
$ 0 |
$ -1 |
- |
Proteostasis Therapeutics Inc |
$ 58 |
$ 6 |
$ -39 |
- |
Alliance Bioenergy Plus, Inc. |
$ 57 |
- |
$ -11 |
- |
American Cryostem Corp |
$ 54 |
$ 1 |
$ -1 |
- |
Pulmatrix Inc |
$ 52 |
$ 12 |
$ -20 |
- |
Asterias Biotherapeutics, Inc. |
$ 51 |
$ 3 |
$ -24 |
- |
Soligenix Inc |
$ 49 |
$ 3 |
$ -15 |
- |
Guided Therapeutics Inc |
$ 48 |
$ 0 |
$ -1 |
- |
Nutra Pharma Corp |
$ 45 |
$ 0 |
$ -4 |
- |
Cadus Corp |
$ 42 |
- |
$ -3 |
- |
Atyr Pharma Inc |
$ 42 |
$ 9 |
$ -17 |
- |
Azurrx Biopharma Inc |
$ 41 |
- |
$ -17 |
- |
Enzon Pharmaceuticals Inc |
$ 40 |
$ 0 |
$ -1 |
- |
Protokinetix Inc |
$ 39 |
- |
$ -10 |
- |
Precipio Inc |
$ 39 |
$ 5 |
$ -9 |
- |
Intelgenx Technologies Corp |
$ 36 |
$ 1 |
$ -8 |
- |
Brickell Biotech Inc |
$ 33 |
$ 9 |
$ -5 |
- |
Iterum Therapeutics Plc |
$ 33 |
- |
$ -64 |
- |
Mymetics Corp |
$ 33 |
$ 1 |
$ -5 |
- |
Inhibitor Therapeutics Inc |
$ 32 |
- |
$ -1 |
- |
Salarius Pharmaceuticals inc |
$ 32 |
$ 6 |
$ -6 |
- |
Integrated Biopharma Inc |
$ 30 |
$ 57 |
$ 5 |
- |
Fusion Pharmaceuticals Inc |
$ 28 |
- |
$ 0 |
- |
Sun Biopharma Inc |
$ 27 |
- |
$ -5 |
- |
Obalon Therapeutics Inc |
$ 27 |
$ 2 |
$ -16 |
- |
Arca Biopharma Inc |
$ 25 |
- |
$ -6 |
- |
Akers Biosciences Inc |
$ 25 |
$ 1 |
$ -16 |
- |
Cyanotech Corp |
$ 24 |
$ 32 |
$ 1 |
124 |
Q Biomed Inc |
$ 24 |
$ 0 |
$ -13 |
8 |
Seneca Biopharma Inc |
$ 23 |
$ 0 |
$ -14 |
- |
Predictive Oncology Inc |
$ 22 |
$ 1 |
$ -27 |
- |
Glucose Health, Inc. |
$ 21 |
- |
$ 0 |
1 |
Checkmate Pharmaceuticals Inc |
$ 20 |
- |
$ 0 |
- |
Health Discovery Corp |
$ 18 |
$ 2 |
$ 3 |
- |
Cell Medx Corp |
$ 18 |
$ 0 |
$ -1 |
4 |
Cannapharmarx Inc |
$ 17 |
- |
$ -18 |
- |
Amarillo Biosciences Inc |
$ 16 |
$ 0 |
$ -1 |
- |
Sunwin Stevia International Inc |
$ 16 |
$ 24 |
$ -2 |
- |
Xenetic Biosciences Inc |
$ 15 |
$ 0 |
$ -11 |
- |
Iteos Therapeutics Inc |
$ 15 |
- |
$ 0 |
- |
Cyclo Therapeutics Inc |
$ 13 |
$ 1 |
$ -9 |
6 |
Pivot Pharmaceuticals Inc. |
$ 13 |
- |
$ -7 |
- |
Prana Biotechnology Ltd |
$ 11 |
$ 0 |
$ -8 |
- |
Mateon Therapeutics Inc |
$ 11 |
- |
$ 0 |
- |
Aevi Genomic Medicine, Inc. |
$ 11 |
- |
$ -18 |
- |
Quest Patent Research Corp |
$ 11 |
$ 8 |
$ -1 |
2 |
Alpha Network Alliance Ventures Inc. |
$ 10 |
$ 0 |
$ -1 |
7 |
Pds Biotechnology Corp |
$ 9 |
- |
$ -15 |
- |
Nexien Biopharma Inc |
$ 9 |
- |
$ -3 |
- |
Sangui Biotech International Inc |
$ 9 |
$ 0 |
$ 0 |
- |
Respirerx Pharmaceuticals Inc |
$ 9 |
- |
$ -4 |
- |
Qrons Inc |
$ 8 |
- |
$ -1 |
- |
Burzynski Research Institute Inc |
$ 8 |
- |
$ -1 |
- |
Gtx Corp |
$ 8 |
$ 1 |
$ 0 |
- |
Kazia Therapeutics Ltd |
$ 7 |
$ 1 |
$ -12 |
- |
Replicel Life Sciences Inc. |
$ 7 |
- |
$ -2 |
- |
Nascent Biotech Inc |
$ 7 |
- |
$ -4 |
- |
Vitality Biopharma Inc |
$ 7 |
$ 0 |
$ -1 |
- |
Bohai Pharmaceuticals Group, Inc. |
$ 7 |
$ 165 |
$ 22 |
- |
American Bio Medica Corp |
$ 6 |
$ 4 |
$ -1 |
- |
Procyon Corp |
$ 6 |
$ 4 |
$ 0 |
- |
Armata Pharmaceuticals Inc |
$ 6 |
$ 0 |
$ -22 |
- |
Iovance Biotherapeutics Inc |
$ 5 |
- |
$ -260 |
- |
Cannabis Global Inc |
$ 5 |
- |
$ -5 |
- |
Gt Biopharma Inc |
$ 5 |
- |
$ -15 |
- |
Sienna Biopharmaceuticals, Inc. |
$ 4 |
- |
$ -48 |
- |
Multicell Technologies, Inc. |
$ 4 |
$ 0 |
$ -1 |
- |
Boston Therapeutics Inc |
$ 4 |
$ 0 |
$ -3 |
- |
Conversion Labs Inc |
$ 3 |
$ 28 |
$ -28 |
11 |
Mitesco Inc |
$ 3 |
- |
$ -4 |
1 |
Oncbiomune Pharmaceuticals Inc |
$ 3 |
$ 0 |
$ -10 |
- |
Global Future City Holding Inc. |
$ 3 |
$ 3 |
$ -5 |
- |
Ridgefield Acquisition Corp |
$ 3 |
- |
$ 0 |
- |
Innovus Pharmaceuticals, Inc. |
$ 2 |
$ 23 |
$ -8 |
- |
Mabvax Therapeutics Holdings, Inc. |
$ 2 |
- |
$ -20 |
- |
Entest Group Inc |
$ 2 |
- |
$ 0 |
- |
United Cannabis Corp |
$ 1 |
$ 16 |
$ -21 |
- |
Cardax Inc |
$ 1 |
$ 1 |
$ -5 |
- |
Cannapowder Inc |
$ 1 |
- |
$ -3 |
- |
Genethera Inc |
$ 1 |
- |
$ -1 |
- |
Aeolus Pharmaceuticals, Inc. |
$ 1 |
$ 1 |
$ -4 |
- |
Green Planet Bio Engineering Co Ltd |
$ 1 |
- |
$ 0 |
- |
Spotlight Innovation Inc. |
$ 1 |
$ 0 |
$ -5 |
2 |
Entia Biosciences, Inc. |
$ 1 |
$ 0 |
$ -1 |
- |
Proteo Inc |
$ 1 |
$ 0 |
$ 0 |
- |
Rich Pharmaceuticals, Inc. |
$ 1 |
- |
$ 0 |
- |
Endonovo Therapeutics Inc |
$ 1 |
$ 0 |
$ -4 |
- |
Skinvisible Inc |
$ 1 |
$ 0 |
$ -2 |
- |
Enumeral Biomedical Holdings, Inc. |
$ 0 |
$ 2 |
$ -13 |
- |
Premier Biomedical Inc |
$ 0 |
$ 0 |
$ 0 |
- |
Hst Global Inc |
$ 0 |
- |
$ 0 |
- |
Tongli Pharmaceuticals (usa), Inc. |
$ 0 |
- |
$ 0 |
- |
Biorestorative Therapies, Inc. |
$ 0 |
$ 0 |
$ -17 |
- |
Intellect Neurosciences, Inc. |
$ 0 |
- |
$ -15 |
- |
Regen Biopharma Inc |
$ 0 |
- |
$ -5 |
- |
Banner Energy Services Corp |
$ 0 |
- |
$ 7 |
- |
Epicure Charcoal, Inc. |
$ 0 |
- |
$ 0 |
- |
Ds Healthcare Group, Inc. |
$ 0 |
$ 12 |
$ -6 |
105 |
Immune Therapeutics Inc |
$ 0 |
- |
$ 2 |
- |
Cure Pharmaceutical Holding Corp |
- |
$ 1 |
$ 6 |
1 |
Apollo Endosurgery, Inc. |
- |
$ 64 |
$ -28 |
- |
Avricore Health Inc |
- |
- |
$ 0 |
- |
Senesco Technologies Inc |
- |
- |
$ 0 |
- |
N-viro International Corporation |
- |
- |
$ 0 |
- |
Axon Enterprise inc |
- |
$ 681 |
$ -2 |
- |
Warner Chilcott Plc |
- |
- |
$ 0 |
- |
Fennec Pharmaceuticals Inc |
- |
- |
$ -18 |
- |
Dna Testing Centers Corp |
- |
$ 0 |
$ 0 |
- |
Immuron Ltd |
- |
$ 3 |
$ -3 |
- |
Immucor Inc |
- |
- |
$ 0 |
- |
China Biologic Products Holdings Inc |
- |
$ 504 |
$ 163 |
- |
Ariad Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
Hyperion Therapeutics Inc |
- |
- |
$ 0 |
- |
Cv Sciences, Inc. |
- |
$ 22 |
$ -5 |
- |
Eastgate Biotech Corp |
- |
$ 0 |
$ -3 |
- |
Mj Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
Lazuriton Nano Biotechnology u s a Inc |
- |
- |
$ 0 |
- |
Mateon Therapeutics Inc |
- |
- |
$ -10 |
- |
Quint Media Inc. |
- |
- |
$ 0 |
- |
Lescarden Inc |
- |
- |
$ 0 |
- |
Medicure Inc |
- |
$ 15 |
$ -15 |
- |
Artemis Therapeutics Inc |
- |
- |
$ 0 |
1 |
Senesco Technologies Inc |
- |
- |
$ -8 |
- |
Receptos, Inc. |
- |
- |
$ 0 |
- |
Kubota Pharmaceutical Holdings Co Ltd |
- |
- |
$ 0 |
- |
Quint Media Inc. |
- |
- |
$ 0 |
- |
Taxus Pharmaceuticals Holdings, Inc. |
- |
- |
$ 0 |
- |
Regenocell Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Ruthigen, Inc. |
- |
- |
$ 0 |
- |
Targacept Inc |
- |
- |
$ 0 |
- |
Vilacto Bio Inc. |
- |
$ 0 |
$ -1 |
1 |
China Kangtai Cactus Bio-tech, Inc. |
- |
- |
$ 0 |
- |
Micromet, Inc. |
- |
- |
$ 0 |
- |
Hubei Minkang Pharmaceutical Ltd. |
- |
- |
$ 0 |
- |
Nutrastar International Inc. |
- |
- |
$ 0 |
- |
Luckwel Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
Restorgenex Corp |
- |
- |
$ 0 |
- |
Ventrus Biosciences Inc |
- |
- |
$ 0 |
- |
Therapix Biosciences Ltd. |
- |
- |
$ 0 |
- |
Savient Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
China Botanic Pharmaceutical |
- |
- |
$ 0 |
- |
Myrexis, Inc. |
- |
- |
$ 0 |
- |
Radient Pharmaceuticals Corp |
- |
- |
$ 0 |
- |
Trius Therapeutics Inc |
- |
- |
$ 0 |
- |
Aytu Bioscience, Inc. |
- |
- |
$ 0 |
- |
Targeted Medical Pharma, Inc. |
- |
- |
$ 0 |
- |
Armo Biosciences, Inc. |
- |
- |
$ 0 |
- |
Chelsea Therapeutics International, Ltd. |
- |
- |
$ 0 |
- |
Mj Biotech, Inc. |
- |
- |
$ -1 |
2 |
Noho, Inc. |
- |
- |
$ 0 |
- |
Manhattan Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
Amarantus Bioscience Holdings, Inc. |
- |
- |
$ 0 |
- |
Tobira Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Mabvax Therapeutics Holdings, Inc. |
- |
- |
$ 0 |
- |
Xstelos Holdings, Inc. |
- |
- |
$ 0 |
- |
Intellicell Biosciences, Inc. |
- |
- |
$ 0 |
- |
Cellcyte Genetics Corp. |
- |
- |
$ 0 |
- |
Synageva Biopharma Corp |
- |
- |
$ 0 |
- |
Northsight Capital, Inc. |
- |
$ 0 |
$ -2 |
- |
Nugene International, Inc. |
- |
- |
$ 0 |
8 |
Renovacare Inc |
- |
- |
$ -8 |
- |
Midatech Pharma Plc |
- |
$ 2 |
$ -15 |
- |
Shengtai Pharmaceutical, Inc. |
- |
- |
$ 0 |
- |
Nexus Biopharma Inc |
- |
- |
$ 0 |
- |
Gentium S.p.a. |
- |
- |
$ 0 |
- |
Nbty Inc |
- |
- |
$ 0 |
- |
Cannabics Pharmaceuticals Inc |
- |
$ 0 |
$ -13 |
- |
Amarantus Bioscience Holdings, Inc. |
- |
- |
$ 0 |
- |
Cohbar Inc |
- |
- |
$ -15 |
- |
Fennec Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
Bionovo Inc |
- |
- |
$ 0 |
- |
Enzymotec Ltd. |
- |
- |
$ 0 |
124 |
Prolor Biotech, Inc. |
- |
- |
$ 0 |
- |
Weikang Bio-technology Group Co., Inc. |
- |
- |
$ 0 |
- |
Dbv Technologies S a |
- |
- |
$ -172 |
- |
Dendreon Corp |
- |
- |
$ 0 |
- |
Entremed Inc |
- |
- |
$ 0 |
- |
Empowered Products, Inc. |
- |
- |
$ 0 |
- |
Arno Therapeutics, Inc |
- |
- |
$ 0 |
- |
Compass Biotechnologies Inc. |
- |
- |
$ 0 |
- |
Tg Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Skinovation Pharmaceutical Inc |
- |
- |
$ 0 |
- |
U.s. Stem Cell, Inc. |
- |
$ 4 |
$ -4 |
- |
Viropharma Inc |
- |
- |
$ 0 |
- |
Oncovista Innovative Therapies, Inc |
- |
- |
$ 0 |
- |
Ocata Therapeutics, Inc. |
- |
- |
$ 0 |
- |
Bg Medicine, Inc. |
- |
- |
$ 0 |
- |
Beesfree, Inc. |
- |
- |
$ 0 |
- |
Diadexus, Inc. |
- |
- |
$ 0 |
- |
United Bancshares Inc |
- |
- |
$ 0 |
- |
Zai Lab Limited |
- |
$ 13 |
$ -195 |
- |
Regado Biosciences Inc |
- |
- |
$ 0 |
- |
Telik Inc |
- |
- |
$ 0 |
- |
Genetic Technologies Ltd |
- |
$ 0 |
$ -6 |
- |
Cadence Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
Cen Biotech Inc |
- |
- |
$ -6 |
- |
Biotechnology & Drugs Industry |
$ 965,235 |
$ 183,981 |
$ 3,541 |
89,094 |
Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Biotechnology & Drugs Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Biotechnology & Drugs Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Biotechnology & Drugs Industry. |
Earnings Estimates
decrease
Pessimism dominates within Biotechnology & Drugs Industry, as most of the businesses cut their earnings guidance, staggering 66.67 % have revised down earnings outlook. Overall earnings expectations for the Biotechnology & Drugs Industry were cut by %, to the annual earnings expectation of %. |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
|
% Industry
Expected EPS Growth |
Total Ranking # Within Sector # |
|
|
% Industry
Earnings Outlook Revision |
Total Ranking # Within Sector # |
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
In the current quarter 66.67 % of companies, who have issued revenue expectation within Biotechnology & Drugs Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year. |
Sales Expectations unchanged
Among companies who provide sales guidance within Biotechnology & Drugs Industry 33.33 %, have reiterated own sales estimates for the current fiscal year. |
Sales Outlook decrease
In Biotechnology & Drugs Industry, there were no sales guidance decreases |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
% Industry
Expected Revenue Growth |
Total Ranking # Within Sector # |
|
|
% Industry
Revenue Outlook Revision |
Total Ranking # Within Sector # |
|
|
|
Cardiovascular Segment |
Revenues |
Income |
14.75% |
-7.45% |
23.14% |
-12.12% |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Neuroscience Segment |
Revenues |
Income |
14.75% |
-7.45% |
23.14% |
-12.12% |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Anti-Infective Segment |
Revenues |
Income |
14.75% |
-7.45% |
23.14% |
-12.12% |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
Respiratory Segment |
Revenues |
Income |
14.75% |
-7.45% |
23.14% |
-12.12% |
Y/Y |
Q/Q |
Y/Y |
Q/Q |
|
|